No HPB disease subgroups were particularly more vulnerable to COVID-19-related death, although patients with chronic pancreatic condition showed a trend towards significance.
← all excerpts
COVID-19 in patients with hepatobiliary and pancreatic diseases: a single-centre cross-sectional study in East London.
1
—
—